Abstract
The use of telemedicine dates as far back as 50 years ago, when the University of Nebraska used interactive telemedicine to transmit neurologic examinations.1 Since that time, despite advances in available technologies and proven utility of telemedicine in allergy and immunology (AI),2,3 the use of telemedicine by AI physicians remains low.4 With the global spread of the novel coronavirus disease 2019 (COVID-19), AI physicians were abruptly forced to change their mode of health care delivery. Given the need for social distancing and exposure mitigation, many practices quickly adapted to remote encounters from primarily in-person care.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have